Product Information
AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-25 MG TAB is a generic product labeled by Aurobindo Pharma Limited, priced at $4.4144 per EA under NDC 65862083530. Its NADAC has been published 252 times since May 1, 2019.
FDA first approved this application on Dec 19, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-25 MG TAB
Amlodipine, Valsartan and HydrochlorothiazideStrength
5; 25; 160 mg/1; mg/1; mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862083530
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTANApproval Type
Generic (ANDA)
FDA Application
ANDA206180FDA Approved
12/19/2017
TE Code
AB
On Market Since
12/19/2017
Pharmacological Classes
Price Statistics
The NADAC for AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-25 MG TAB has been published 252 times since May 1, 2019, and over the history we have for it it has risen 247.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.4144 per EA |
|---|---|
| All-time high | $7.4082 (May 15, 2024) |
| All-time low | $1.0047 (Dec 18, 2019) |
| 52-week high | $7.0860 |
| 52-week low | $4.4144 |
| Median price | $1.5265 |
| Average price | $3.5640 |
| Largest weekly change | +484.3% (Apr 17, 2024) |
| Weeks tracked | 252 |
| Tracking since | May 1, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Amlodipine, Valsartan and Hydrochlorothiazide market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-25 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-25 MG TAB, manufactured by Aurobindo Pharma Limited, is $4.4144 per EA (NDC 65862083530), effective Aug 19, 2026.
How has the price of AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-25 MG TAB changed over time?
Over the history we have for it, the NADAC for AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-25 MG TAB has risen 247.4%. It has been tracked across 252 weekly CMS publications since May 1, 2019.
What are the highest and lowest recorded NADAC prices for AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-25 MG TAB?
Since May 1, 2019, the NADAC for AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-25 MG TAB has ranged from a low of $1.0047 (Dec 18, 2019) to a high of $7.4082 (May 15, 2024), with a median of $1.5265 per EA.
Are there cheaper alternatives to AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-25 MG TAB?
No other NADAC-published product currently shares the active ingredient and strength of AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-25 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-25 MG TAB?
AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-25 MG TAB (NDC 65862083530) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.